Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-25-121483
Filing Date
2025-12-15
Accepted
2025-12-15 08:49:36
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 19289
2 JOINT FILING AGREEMENT ea026956601ex-1_pluri.htm EX-1 7957
  Complete submission text file 0001213900-25-121483.txt   29392
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA Israel
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA Israel 972-74-710-7171
Pluri Inc. (Subject) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-78785 | Film No.: 251570130
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 4TH FLOOR, LIBERATION HOUSE CASTLE STREET ST HELIER Y9 JE1 4HH
Business Address 4TH FLOOR, LIBERATION HOUSE CASTLE STREET ST HELIER Y9 JE1 4HH 44-1534-823126
Chutzpah Holdings Ltd (Filed by) CIK: 0002055515 (see all company filings)

EIN.: 000000000 | State of Incorp.: Y9 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A